New Chinese Funding Source open for business

Dynasty Biotechnology is pleased to announce commencement of a major partnership with Cambridge-based Nuformix in a long term, multi-product agreement.

The Nuformix biobetter products fit perfectly within the Dynasty portfolio of China-relevant assets to be developed and commercialised in China and rolled out to non-China markets. “We are delighted to be working with Nuformix and to come to agreement on the first set of assets,” commented Dynasty CEO Dr Simon ...

Continue Reading →
2
DEC
0

Blog

, ,

China Beckons

China Beckons

The first point I would like to make about trips to China is this: you soon discover that, despite not understanding their language culture or politics, we in the UK have more in common with the Chinese folks one meets than with the Americans. The Chinese and English are as one people, divided by almost everything except the importance of relationships. And in China, relationships are everything.

This China trip is part of what appears to be my Grant Application Month. First there ...

Continue Reading →
2
DEC
0

Blog

, , , , , , ,

Team Kapital raises £3.9m for CompanDX in China

Team Kapital raises £3.9m for CompanDX in China

CompanDX Limited, the Nottingham Trent University spinout applying novel bio-informatics technology to the issues of personalised medicine, is pleased to announce the raising of 39,600,000 Renminbi (CN¥) for development of products in China. CompanDX was advised by Team Kapital: TK founder Simon Haworth is currently operating as CEO of CompanDX Limited.

“This is an extraordinary step for an early stage technology company and allows us to put a significant capital sum to work,” says Chief Executive Dr Simon Haworth. “The China ...

Continue Reading →
2
DEC
0

Blog

, , , ,

Chasing the dragon? Setting up in China

So, as the ‘white wine’-induced hangover wears off, I realise that I have a new addiction: China.

China is a heady drug for anyone involved in biotech, cleantech or IT, representing a massive potential market, a source of significant funding – both in terms of grant and investment – and offering the potential for rapid product development. It is also a frightening, challenging, bureaucratic, unknown business environment with alien culture and, at first sight, inpenetrable language.

This series of blogs ...

Continue Reading →
2
DEC
0

Blog

, , , , , ,